Concepedia
Statistics
Publications
10
Citations
742
H-Index
Active since
1998
Affiliations
University of Utah(Current)
GlaxoSmithKline (United States)
Konstantine W. Skordos is an author at University of Utah specializing in medicine, pharmacology, and metabolomics.
Top concepts
MedicineBiochemistryMetabolomicsPharmacologyRedox BiologyMetabolismToxicologyCell BiologyBreast CancerTumor Biology
Publications per year
1998–2014
The Conduct of in Vitro Studies to Address Time-Dependent Inhibition of Drug-Metabolizing Enzymes: A Perspective of the Pharmaceutical Research and Manufacturers of America
Scott Grimm, Heidi J. Einolf, Steven D. Hall et al. · Drug Metabolism and Disposition · 2009 · 304 citations
Evaluation of Various Static In Vitro–In Vivo Extrapolation Models for Risk Assessment of the CYP3A Inhibition Potential of an Investigational Drug
Md L T Vieira, Brian J. Kirby, Isabelle Ragueneau‐Majlessi et al. · Clinical Pharmacology & Therapeutics · 2013 · 101 citations
Zafirlukast Metabolism by Cytochrome P450 3A4 Produces an Electrophilic α,β-Unsaturated Iminium Species That Results in the Selective Mechanism-Based Inactivation of the Enzyme
Kelem Kassahun, Konstantine W. Skordos, Ian McIntosh et al. · Chemical Research in Toxicology · 2005 · 72 citations
The Metabolic Drug-Drug Interaction Profile of Dabrafenib: In Vitro Investigations and Quantitative Extrapolation of the P450-Mediated DDI Risk
Sarah K. Lawrence, Dung N. Nguyen, Chet Bowen et al. · Drug Metabolism and Disposition · 2014 · 52 citations
Inhibition of Polo-like kinase 1 prevents the growth of metastatic breast cancer cells in the brain
Yongzhen Qian, Emily Hua, Kheem S. Bisht et al. · Clinical & Experimental Metastasis · 2011 · 47 citations · Full text
Medicine, Receptor Tyrosine Kinase, Breast Cancer +8
1–5 of 10